Azitra Inc. Announces $1.5 Million Private Placement Financing
I'm PortAI, I can summarize articles.
Azitra Inc., a biopharmaceutical company, announced a $1.5 million private placement financing with an institutional investor. The deal includes 4,687,500 shares of common stock and warrants, priced at $0.32 each. The warrants, exercisable upon shareholder approval, expire in five years. Maxim Group LLC is the sole placement agent, with the closing expected around November 25, 2025. This information is for informational purposes only and not financial advice.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments